755 Logo (Mirtazapine 45 mg)
Pill imprint 755 Logo has been identified as Mirtazapine 45 mg.
Mirtazapine is used in the treatment of insomnia; major depressive disorder; anxiety; depression; hot flashes (and more), and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 45 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- 755 Logo
- Strength:
- 45 mg
- Color:
- White
- Size:
- 11.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Tetracyclic antidepressants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 62037-0755
- Inactive Ingredients:
- silicon dioxide colloidal
crospovidone
hypromellose 2910 3cp
hypromellose 2910 6cp
hypromellose 2910 50cp
lactose monohydrate
magnesium stearate
polydextrose
polyethylene glycol
polyethylene glycol 400
polyethylene glycol 8000
pregelatinized starch
titanium dioxide
triacetin
More about mirtazapine
Consumer resources
- Other brands: Remeron, Remeron SolTab
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
